Arkolith/Insider Trading/TVTX/Form 4

Baynes Roy D.

DirectorTravere Therapeutics, Inc. (TVTX) · full profile →Form 4 · filed May 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$210K
Net Open-Market Flow
-$210K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 5, 2026Option exercise(M)5K$18.27$82K42K
May 5, 2026Sell(S)5K$46.65$210K38K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 5, 2026Option exercise(M)5K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001680739-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML